🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism

RecruitingNAAges 1 Year - anyAllIRCCS Eugenio Medea
NCT07389720 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this interventional study is to understand whether sensorimotor skills could represent an endophenotype for autism, i.e. a specific class of biomarkers that bridges the gap between biological components of a condition and the behavioral/clinical dimensions. Motor and sensory differences are often observed in people with autism and may appear early in development or be shared among family members. The study will address three main questions: * What are the developmental effects of early differences in motor and sensory skills? * Are motor and sensory abilities influenced by family relationships? * Can studying motor and sensory differences in autism help researchers better understand the biological mechanisms underlying the condition? This study is structured in three topic-oriented work packages (WPs): WP1, a longitudinal assessment of sensorimotor skills as early predictor

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * children aged 2 to 12 years (both autistic and typically developing) * Clinical diagnosis of Autism Spectrum Disorder based on clinical judgment according to DSM-5 criteria (for the autism group). * being parents of the enrolled children (both autistic and typically developing) * infants younger than 24 months of age with a first-degree family member with a clinical diagnosis of Autism Spectrum Disorder. Exclusion Criteria: * Presence of medical and/or neurological conditions of clinical significance, including epilepsy. * Presence of dysmorphic syndromes or known genetic syndromes. * Current use of medications and/or psychotropic drugs.
💊

What it tests

  • clinical assessment
  • Neuropsychological examination
  • Neurophysiological evaluation
  • Genetic evaluation
📍

Where

1 site
IRCCS E. Medea
Bosisio Parini, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy